GetPortalImpactFactorByIdResp(projectId=1, id=69e82366, cover=https://img.medsci.cn/images/journal/cover/2021/eaF_202109271315012170.jpg, fullname=EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, abbr=EXP CLIN PSYCHOPHARM, pyear=1993, frequence=Bimonthly, articleNumbers=1403, citedSelf2015=8.6, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2019年中国人文章占该期刊总数量∞% (2018年为暂无数据), issn=1064-1297, greenSci=https://www.greensci.net/search?kw=1064-1297, scijournal=https://www.scijournal.org/impact-factor-of-EXP-CLIN-PSYCHOPHARM.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.193, medsciHotlight=0.771, medsciHotlight5year=1.73161, citescore=4.1, hIndex=92, impactFactor=2.3, orgnization=American Psychological Association Inc., orgnizationUrl=http://www.apa.org/, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Social Sciences Citation Index|BIOSIS Previews, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=http://content.apa.org/journals/pha, websiteHits=3620, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=https://www.editorialmanager.com/pha/default.aspx, submitWebsiteHits=953, content=Experimental and Clinical Psychopharmacology seeks to promote the discipline of psychopharmacology in its fullest diversity. Psychopharmacology necessarily involves behavioral change, psychological processes, or their physiological substrates as one central variable and psychopharmacological agents as a second central variable. Such agents will include drugs, medications, and chemicals encountered in the workplace or environment. One goal of the journal is to foster basic research and the development of theory in psychopharmacology. Another is to encourage the integration of basic and applied research, the development of better treatments for drug abuse, and more effective pharmacotherapeutics. To this end, the journal publishes original empirical research involving animals or humans that spans (a) behavioral pharmacology research on social, behavioral, cognitive, emotional, physiological, and neurochemical toxicity; (b) descriptive and experimental studies of drug abuse, including its etiology, progression, adverse effects, and behavioral and pharmacological treatment; and (c) controlled clinical trials that, in addition to improving the effectiveness, range, or depth of application, will increase our understanding of psychological functions or their drug modulation. The journal also publishes theoretical and integrative analyses and reviews that promote our understanding and further systematic research in psychopharmacology. The journal also publishes papers in two other sections, Innovations and Remarks. Innovations is an occasional section that will highlight papers that establish a novel method, a novel result, a novel measure, or a new theory. Commentary may be solicited to address the nature of the innovation and to provide contrasting views. Remarks is another occasional section. The purpose of "remarks" is for brief commentary about important aspects of the field that have not been previously addressed or considered. Remarks could address either empirical or theoretical issues. Remarks are expected to be erudite, integrative, substantive, and thoughtful. Although case studies are not appropriate, occasional small sample experiments with special populations may be considered. The journal is intended to be informative and useful to both basic and applied researchers and to practitioners operating in varied settings. Experimental and Clinical Psychopharmacology seeks to be the vehicle for the best research ideas and for integrating pharmacology and behavior., totalCites=3229, brief=EXP CLIN PSYCHOPHARM杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=精神病学" >精神病学</a></strong>”子行业的偏低级别杂志, articleType=该刊全部是论著，可能不接收综述类等文章, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=EXP CLIN PSYCHOPHARM杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=69e82366'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.35), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.56), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.51), GetImpactFactorCiteScoreListResponse(year=2019, citescore=3.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=1.88), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.949), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.819), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.092), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.193)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Psychiatry and Mental Health , rank=128/494), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=76/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=113/300)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q2), GetImpactFactorCiteScoreGradeResponse(smallClass=PSYCHIATRY, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1064-1297[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY[ta], article_number=101, article_number_cn=0, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)